We are live on
!
Find out more
RCP
Rho Capital Partners Portfolio holdings
AUM
$20.4M
This Fund
S&P 500
This Quarter
Est. Return
+17.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.09B
AUM Growth
+$52.7M
(+5.1%)
Cap. Flow
-$42.7M
Cap. Flow
% of AUM
-3.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ChargePoint
CHPT
|
+$24.2M |
| 2 |
TVRD
Tvardi Therapeutics
TVRD
|
+$18.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 76.77% |
| 2 | Technology | 11.81% |
| 3 | Healthcare | 9.8% |
| 4 | Communication Services | 1.61% |
Similar funds
LUGPI
IVM
SIC
DOS
AA
CVSCT
VNB
BEP
Rho Capital Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Rho Capital Partners held 7 positions worth $1.09B, up 5.1% from $1.04B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Rho Capital Partners withdrew a net $42.7M in Q2 2021, reducing 2 holdings. Its largest reduction was ChargePoint, cutting an estimated $24.2M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 77% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.
- Rho Capital Partners's biggest Q2 2021 reduction was ChargePoint, cutting an estimated $24.2M.
- Rho Capital Partners's ten largest holdings make up 100% of its $1.09B portfolio in Q2 2021.
- Rho Capital Partners opened 0 new positions and closed 0 in Q2 2021.
- Rho Capital Partners's portfolio value rose 5.1% quarter-over-quarter to $1.09B.
Based on Rho Capital Partners's 13F filing for Q2 2021, filed 12 Aug 2021.